Table 7 Costs, cost difference, and net monetary benefit for different input parameters, 18 year time horizon
From: Cost burden and net monetary benefit loss of neonatal hypoglycaemia
Utility Source and Method | Cost method | Discount Rate | Prevalence Source | Cost, NZ$, Hospital and Post-Discharge | Utility, QALYs | Net Monetary Benefit Loss, NZ$ | ||||
|---|---|---|---|---|---|---|---|---|---|---|
|  |  |  |  | Neonatal Hypoglycaemia | No Neonatal Hypoglycaemia | Difference | Neonatal Hypoglycaemia | No Neonatal Hypoglycaemia | λ  = $43 k | λ = $14 k |
Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $39,431.82 | $3590.91 | $35,840.91 | 10.48 | 11.78 | $92,149.00 | $54,610.28 |
Kwon et al., minimum value | Sum of all outcomes | 3.5% | Mean, all outcomes | $39,241.22 | $3572.01 | $35,669.20 | 10.48 | 11.78 | $91,978.93 | $54,438.77 |
Kwon et al., product of values | Outcome with greatest cost | 3.5% | Mean, all outcomes | $39,281.48 | $3581.04 | $35,700.45 | 10.45 | 11.78 | $93,319.29 | $54,905.74 |
Petrou et al., minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $39,552.32 | $3599.79 | $35,952.54 | 10.89 | 12.43 | $102,809.90 | $58,237.90 |
Carrol et al., TTO, minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $39,389.59 | $3586.38 | $35,803.21 | 12.38 | 13.51 | $84,831.79 | $52,145.75 |
Carrol et al., SG, minimum value | Outcome with greatest cost | 3.5% | Mean, all outcomes | $39,250.22 | $3596.91 | $35,653.32 | 12.37 | 13.51 | $84,792.87 | $52,033.33 |
Kwon et al., minimum value | Outcome with greatest cost | 0.0% | Mean, all outcomes | $49,365.56 | $4368.33 | $44,997.22 | 13.82 | 15.53 | $119,268.94 | $69,753.46 |
Kwon et al., minimum value | Outcome with greatest cost | 5.0% | Mean, all outcomes | $36,101.08 | $3333.21 | $32,767.87 | 9.42 | 10.59 | $83,435.22 | $49,656.72 |
Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Minimum, all outcomes | $19,072.44 | $3606.86 | $15,465.57 | 11.48 | 11.78 | $28,324.82 | $19,752.29 |
Kwon et al., minimum value | Outcome with greatest cost | 3.5% | Mean, with vision disorders and epilepsy values equal to population without hypoglycaemia | $40,166.02 | $3597.08 | $36,568.94 | 10.44 | 11.78 | $94,489.58 | $55,875.70 |